PainChek Expands Sabra Contracts to 23 US Communities
Key points
- PainChek expands to 23 Sabra communities
- Focus on assisted living and memory care
- Targeting 808 memory care licenses
- Priority on converting contracts to revenue
Full summary
PainChek Limited (ASX: PCK) has expanded its commercial uptake under its Master Services Agreement with Sabra Health Care REIT, Inc. (Nasdaq: SBRA). This expansion extends PainChek's footprint from the initial two memory care facilities announced in June 2026 to 23 communities across five operators. PainChek's US sales execution prioritizes assisted living and memory care, an estimated 1.2 million potential license opportunity. The company aims to convert contracted uptake into implemented annual recurring revenue (ARR) by 31 December 2026. PainChek is also pursuing further adoption throughout Sabra's portfolio and additional US assisted living and memory care operators.
Guidance
PainChek aims to convert 808 memory care licenses into implemented annual recurring revenue (ARR) by 31 December 2026.
Outlook
PainChek's near-term priority is to convert contracted uptake into recurring revenue. The company is also progressing relationships and pipeline opportunities with additional US assisted living and memory care operators.
Summary generated by a large language model. Please interpret with care.